We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
  • SKIP TO CONTENT
  • SKIP NAVIGATION
  • Drug Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Device Products
    • Books
    • FDAnews Books Library
    • Events
    • Form 483s Database
    • Subscription Newsletters
    • Free Newsletters
    • Webinar Training Pass
    • eCFR and Guidances
  • Clinical Products
  • Advertising
  • White Papers
  • Contact Us
  • About Us
  • COVID-19
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Dräger, Covidien Recall Ventilators

Dräger, Covidien Recall Ventilators

September 4, 2015

Dräger Medical and Covidien are recalling more than 2,700 ventilators over potentially fatal issues.

The FDA has given Class 1 recall status to more than 2,000 Evita V500 and Babylog VN500 ventilators manufactured and distributed from June 2011 to June 2015 by Dräger over concerns about faulty batteries. Both ventilators provide breathing support for premature babies weighing at least 14 ounces. The Evita model also may be used in children and adults.

As the FDA notes in a post from last week, the ventilator batteries do not last as long as expected, and the indicator light shows sufficient charge even when the battery is depleted. If a ventilator were to shut down, a patient may not receive enough oxygen, leading to potential injury or death.

The company sent an urgent medical device recall letter on July 13 to customers informing them that it plans to replace faulty batteries. Until the batteries are replaced, it advised customers not to rely on the battery status indicator, connect the ventilator to a main power supply if the power alarm sounds and not use the device to transport patients unless necessary.

Covidien Recall

The agency also announced a Class 1 recall of 657 of Covidien’s Puritan Bennett 980 ventilators, produced and distributed between March 2014 and June 2015, over a potential software glitch. The ventilators provide breathing support for premature babies weighing at least 10.6 ounces through adults.

When set to neonatal volume control plus mode with active humidification, the software glitch may cause the amount of air being delivered to be lower than the programmed amount.

The malfunction could result in injury or death.

Covidien sent an urgent field corrective action notice to customers informing them that it intends to implement a software update to correct the error.

Read the Dräger recall notice here: www.fdanews.com/09-08-15-drager.pdf and the Covidien recall notice here: www.fdanews.com/09-08-15-covidien.pdf. — John Bechtel

Postmarket Safety

Upcoming Events

  • 10Mar

    FDA Drug GMP Facility Inspections During the Pandemic

  • 16Mar

    Pharmaceutical Naming Regulation: Understanding the Latest Developments

  • 18Mar

    Pharmaceutical Postmarket Surveillance: Latest Developments in the Era of COVID-19

  • 23Mar

    Data Integrity for GCP Professionals: Core Requirements, Expectations and Challenges

  • 30Mar

    Data Integrity for GMP/Postmarket Professionals: Core Requirements, Expectations and Challenges

  • 06Apr

    Medical Device Cybersecurity: Understand the Latest Developments

Featured Products

  • Biological Risk Evaluation and Management for Medical Devices

  • GMP Inspection Preparation Checklist: A Tool for Internal Auditing

Featured Stories

  • UKflag.jpg

    UK Study Says Single Shot of Pfizer/BioNTech Vaccine Significantly Lessened Asymptomatic Infections

  • emergency use authorization approved

    Eurofins Receives FDA Emergency Authorization for Over-the-Counter COVID-19 Test

  • FDA clears text

    Vetex Medical’s Thrombectomy Catheter Cleared by FDA

  • 100Bills_flatmoney.gif

    Merck Purchases Rights to Debiopharm’s Xevinapant for More Than $1 Billion

The Revised ICH E8: A Guide to New Clinical Trial Requirements

Learn More
  • Drug Products
    • Quality
    • Regulatory Affairs
    • GMPs
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Device Products
    • Quality
    • Regulatory Affairs
    • QSR
    • Inspections and Audits
    • Postmarket Safety
    • Submissions and Approvals
    • Research and Development
    • Commercial Operations
  • Clinical Products
    • Trial Design
    • Data Integrity
    • GCP
    • Inspections and Audits
    • Transparency
  • Privacy Policy
  • Do Not Sell My Personal Information
Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 703.538.7600 – Fax 703.538.7676 – Toll free 888.838.5578

Copyright © 2021. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing